|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print February 4, 2008 J. Lipid Res., doi:10.1194/jlr.M700503-JLR200
Pathology, University of Washington, Seattle, WA 98101
Corresponding Author: tmontine{at}u.washington.edu
Unlike F4-Neuroprostanes (NeuroPs) that are relatively selective in vivo markers of oxidative damage to neuronal membranes, there currently is no method to assess the extent of free radical damage to myelin with relative selectively. The polyunsaturated fatty acid adrenate (AdA) is susceptible to free radical attack, and, at least in primates, is concentrated in myelin within white matter. Here we characterized oxidation products of AdA as potential markers of free radical damage to myelin in human brain. Unesterified AdA was reacted with a free radical initiator to yield products (F2-Dihomo-IsoPs) that were 28 Da larger but otherwise closely resembled F2-Isoprostanes (IsoPs), which are generated by free radical attack on arachidonic acid (AA). Phospholipids derived from human cerebral gray matter, white matter, and myelin similarly oxidized ex vivo showed that the ratio of esterified F2-Dihomo-IsoPs to F4-NeuroPs was approximately 10-fold greater in myelin- than gray matter-derived phospholipids. Finally, we showed that F2-Dihomo-IsoPs are significantly increased in white matter samples from patients with Alzheimers disease. We propose that F2-Dihomo-IsoPs may serve as quantitative in vivo biomarkers of free radical damage to myelin from primate white matter.
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||